Cytarabine release from α,β-poly(N-hydroxyethyl)-dl-aspartamide matrices cross-linked through γ-radiation
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Biopolymer Synthesis and Applications · Hydrogels: synthesis, properties, applications · Synthesis and properties of polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Trouet · 1985 · 1
2. Rihova · 1986 · 289
3. The synthesis and characterization of polypeptide-adriamycin conjugates and its complexes with adriamycin10.1016/0168-3659(85)90006-9 ↗
4. Gambotz · 1986 · Vol. 1 · 95
5. Passive immunotherapy of cancer: perspectives and problems10.1016/0168-3659(91)90034-B ↗
6. Macromolecular prodrugs for use in targeted cancer chemotherapy: melphalan covalently coupled to N-(2-hydroxypropyl)methacrylamide copolymers10.1016/0168-3659(91)90036-D ↗
7. Cytosine arabinoside: molecular, pharmacokinetic and cytokinetic considerations10.1016/0163-7258(84)90044-5 ↗
8. Antiviral effect of antileukemic drugs N4-behenoyl-1-β-d-arabinofuranosylcytosine (BH-AC) and 2,2′-anhydro-1-β-d-arabinofuranosylcytosine (cyclo-C) against human cytomegalovirus10.1002/jmv.1890310212 ↗
9. Properties of a 9-(2-phosphonyl methoxyethyl)adenine (PMEA)-resistant herpes simplex virus type 1 virus mutant10.1016/0166-3542(90)90049-D ↗
10. Effect of cytosine arabinoside on the human immunosystem: metabolism and cytotoxicity studied with mitogen-stimulated normal blood lymphocytes in vitro10.1016/0192-0561(88)90078-1 ↗
11. Differential toxicity of cytosine arabinoside to cell kinetics in normal sheep sinus cells and sheep tumor cell line in vitro10.1016/0887-2333(90)90036-S ↗
12. Circulating carrier erythrocytes: slow-release vehicle for an antileukemic drug, cytosine arabinoside
13. Preparation of liposome-encapsulated antitumor drugs; relationship between lipophilicity of drugs and in vitro drug release10.1248/cpb.32.1929 ↗
14. Release of cytarabine from biodegradable poly(γ-benzyl-l-glutamate) block copolymer microsphere
15. Conjugate of N4-(4-carboxybutyryl)-ara-C and ethylenediamineintroduced dextran. Drug release profiles and further in vivo study of its antitumor effects
16. Synthesis of α,β-poly[(2-hydroxyethyl)-dl-aspartamide], a new plasma expander10.1021/jm00266a006 ↗
17. Pharmacological and toxicological evaluation of polyhydroxyethylaspartamide (PHEA) as a plasma substitute
18. Polyaspartamide. A potential drug carrier
19. Suppression of IgE antibody response against ovoalbumin by the chemical conjugate of ovoalumin with a polyaspartic acid derivative10.1159/000233666 ↗
20. Reaction of α,β-poly(N-hydroxyethyl)-dl-aspartamide with derivatives of carboxylic acids10.1002/pola.1987.080251016 ↗
21. Anticancer agent coupled to polyaspartamide as a drug carrier
22. Water-soluble copolymers of an antiviral agent: synthesis and their interaction with a biomembrane model10.1016/0168-3659(92)90094-8 ↗
23. Synthesis and therapeutic potential of a macromolecular prodrug of diflunisal10.1016/0378-5173(94)90235-6 ↗
24. Calderaro · 1980 · Vol. 3
25. Influence of the drug solubility and dissolution medium on the release from poly(2-hydroxyethyl methacrylate) microspheres10.1016/0168-3659(87)90006-X ↗
26. Mechanisms of solute release from porous hydrophilic polymers10.1016/0378-5173(83)90064-9 ↗
27. Analysis of non-Fickian transport in polymer using simplified exponential expressions10.1016/S0376-7388(00)83223-8 ↗
28. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices10.1016/0168-3659(87)90035-6 ↗
29. A simple equation for the description of solute release. II. Coupling of diffusion and relaxation10.1016/0378-5173(89)90306-2 ↗
30. Baker · 1974 · 15